| 000 | 01373 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511205807.0 | ||
| 264 | 0 | _c19911120 | |
| 008 | 199111s 0 0 eng d | ||
| 022 | _a0950-3536 | ||
| 024 | 7 |
_a10.1016/s0950-3536(05)80167-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChessells, J M | |
| 245 | 0 | 0 |
_aMyelodysplasia. _h[electronic resource] |
| 260 |
_bBailliere's clinical haematology _cApr 1991 |
||
| 300 |
_a459-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBone Marrow _xpathology |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 7 |
| 650 | 0 | 4 |
_aColony-Stimulating Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aDown Syndrome _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMonosomy |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xclassification |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aWhole-Body Irradiation |
| 773 | 0 |
_tBailliere's clinical haematology _gvol. 4 _gno. 2 _gp. 459-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0950-3536(05)80167-2 _zAvailable from publisher's website |
| 999 |
_c1839206 _d1839206 |
||